Skip to content
Peptide Field Notes
All peptides

Aesthetics / tanning

Melanotan-2 Dosage: Why I Say Tread Carefully

A tanning peptide that works, with safety flags I will not wave away.

KennyMelanotan-2 (MT-2)Last reviewed June 2026

The quick version

  • A tanning peptide. Never approved for human use anywhere.
  • Real safety flags: melanoma case reports, plus heart and kidney risks.
  • This is the rare one I would just skip.

What it is

Melanotan-2 is a lab-made peptide that makes your skin tan with less sun, by switching on the cells that make pigment. It has never been approved for human use anywhere.

What the research shows

This is the one I am most cautious about. No phase 3 trial has set a safe dose in humans. The longest published human study ran 8 weeks and stopped early for side effects. There are case reports of melanoma showing up in moles during or after use, plus documented heart, kidney, and priapism risks (case reports and safety reviews, 2025). The tan is real, the safety is not.

What it felt like

I have not run melanotan-2, and I am not going to start. The risk profile is the reason. I am covering it because people ask, not because I think it is a smart pick.

Dosing reality

People share small loading doses followed by maintenance, but since no trial set a safe range, any number is a guess built on anecdote. I am not going to print a dose I would not use myself.

The one mistake to avoid

The biggest mistake is treating it like a harmless tanning shortcut. A new or changing mole is a reason to see a doctor, not to keep dosing.

Bottom line

Melanotan-2 works for tanning, but it is unapproved with real safety flags. This is the rare one where I would just skip it.

Reminder: I am not a doctor and this is not medical advice. It is my own notes and reading of the research. Peptides sit in a legal grey area, research-grade is a real category, and it is on you to verify your own compliance. Talk to a qualified professional before you start anything, especially if you take other medication.